2,106
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Airflow Obstruction and Cardio-metabolic Comorbidities

, , , , , , & show all
Pages 109-117 | Received 18 Nov 2018, Accepted 29 Apr 2019, Published online: 27 May 2019

References

  • WHO. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2015 global survey. Geneva: World Health Organization, 2016.
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi: 10.1164/rccm.201701-0218PP.
  • Franssen FME, Soriano JB, Roche N, et al. Lung Function Abnormalities in Smokers with Ischemic Heart Disease. Am J Respir Crit Care Med. 2016;194(5):568–576. doi: 10.1164/rccm.201512-2480OC.
  • Chen W, Thomas J, Sadatsafavi M, et al. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi: 10.1016/S2213-2600(15)00241-6.
  • Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of copd in national and international surveys. Chest. 2015;148(4):971–985. doi: 10.1378/chest.14-2535.
  • Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005;2(2):277–283.
  • Perez-Padilla R, Vazquez-Garcia JC, Marquez MN, et al. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care. 2006;51(10):1167–1171.
  • American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152(3):1107–1136.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi: 10.1164/ajrccm.159.1.9712108.
  • Coton S, Vollmer WM, Bateman E, et al. Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification. COPD. 2017;5:469–475. doi: 10.1080/15412555.2017.1339681.
  • Miller MR, Levy ML. Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ. 2015;351:h3021.
  • World Bank. World Development Indicators 2015. Washington, DC: World Bank, 2015.
  • Jousilahti P, Vartiainen E, Tuomilehto J, et al. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99(9):1165–1172.
  • Falkstedt D, Hemmingsson T. Educational level and coronary heart disease: a study of potential confounding from factors in childhood and adolescence based on the Swedish 1969 conscription cohort. Ann Epidemiol. 2011;21(5):336–342. doi: 10.1016/j.annepidem.2010.12.005.
  • Bogers RP, Bemelmans WE, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720–1728. doi: 10.1001/archinte.167.16.1720.
  • Tolstrup JS, Hvidtfeldt UA, Flachs EM, et al. Smoking and risk of coronary heart disease in younger, middle-aged, and older adults. Am J Public Health. 2014;104(1):96–102. doi: 10.2105/AJPH.2012.301091.
  • Lubin JH, Couper D, Lutsey PL, et al. Risk of cardiovascular disease from cumulative cigarette use and the impact of smoking intensity. Epidemiology. 2016;27(3):395–404. doi: 10.1097/EDE.0000000000000437.
  • Burney P. Coming off the GOLD standard. Lancet Respir Med. 2014;2(3):174–6. doi: 10.1016/S2213-2600(14)70040-2.
  • Baty F, Putora PM, Isenring B, et al. Comorbidities and burden of COPD: a population based case-control study. PLoS One. 2013;8(5):e63285. doi: 10.1371/journal.pone.0063285.
  • Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics. 1946;2(3):47–53.
  • Lange P, Mogelvang R, Marott JL, et al. Cardiovascular morbidity in COPD: a study of the general population. COPD. 2010;7(1):5–10. doi: 10.3109/15412550903499506.
  • Lindberg A, Larsson LG, Ronmark E, et al. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD. 2011;8(6):421–428. doi: 10.3109/15412555.2011.629858.
  • Joosten MM, Pai JK, Bertoia ML, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308(16):1660–1667. doi: 10.1001/jama.2012.13415.
  • Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605. doi: 10.1136/thx.2007.088112.
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi: 10.1183/09031936.00012408.
  • Garcia-Rio F, Soriano JB, Miravitlles M, et al. Overdiagnosing subjects with COPD using the 0.7 fixed ratio: correlation with a poor health-related quality of life. Chest. 2011;139(5):1072–1080. doi: 10.1378/chest.10-1721.
  • Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–1518. doi: 10.1016/S0140-6736(08)60655-8.
  • Vanfleteren LE, Lamprecht B, Studnicka M, et al. Body mass index and chronic airflow limitation in a worldwide population-based study. Chron Respir Dis. Chron Respir Dis. 2016;13(2):90–101. doi: 10.1177/1479972315626012.